期刊
ACS APPLIED MATERIALS & INTERFACES
卷 9, 期 20, 页码 17418-17427出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsami.7b02809
关键词
beta-CD-(D-3)(7); siRNA; matrix metalloproteinase-9; diabetic wound healing; RNA interference
资金
- Natural Science Foundation of China [81500640, 81471034, 81270916, 81370910, 81670764]
- Guangzhou Major People's Livelihood Project [201300000102]
- Applied Science and Technology Research and Development in Guangdong Province [2016B020238001]
- High Technology Research and Development Program [2015AA020927]
- Science and Technology Special Project in Guangdong Province [2016A010103014]
- Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology
- Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes
Overexpression of matrix metalloproteinase-9 (MMP-9) is critical for diabetic chronic wounds involved in the refractory wound healing process. We aimed to develop a strategy through RNAi to decrease MMP-9 expression and improve diabetic wound healing. We had explored beta-CD-(D-3)(7) as a gene carrier to take siRNA and effectively interfere with MMP-9 expression. It has been proven that beta-CD-(D-3)(7) could be used as an effective siRNA delivery system. In this study, we want to know about the efficiency and safety of beta-CD-(D-3)(7)/MMP-9 siRNA for improving wound healing in diabetic rats. beta-CD-(D-3)(7)/MMP-9 siRNA treated animals show lower levels of MMP-9 expression, which induce faster wound-close rates. Histological evaluation indicates that beta-CD-(D-3)(7)/MMP-9 siRNA significantly increases the content of collagen around the injured tissues. The number of neutrophilic ganulocytes was significantly decreased through treatment of beta-CD-(D-3)(7)/MMP-9 siRNA. In vivo fluorescence imaging assessment shows that beta-CD-(D-3)(7)/MMP-9 siRNA could not cause organ damage and organ accumulation. The results suggest that beta-CD-(D-3)(7)/MMP-9 siRNA might be developed as a novel topical agent for the diabetic wounds treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据